World News
Eli Lilly looks beyond GLP-1s with a $3 billion cancer buy

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Eli Lilly announced it will acquire Kelonia Therapeutics for $3.25 billion upfront to expand its oncology and genetic medicines pipeline



